We are live on ! Find out more
LAB icon

Standard BioTools
LAB

84 hedge funds and large institutions have $227M invested in Standard BioTools in 2018 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 27 increasing their positions, 28 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

44% more call options, than puts

Call options by funds: $189K | Put options by funds: $131K

2.34% more ownership

Funds ownership: 95.42% → 97.77% (+2.3%)

5% more capital invested

Capital invested by funds: $217M → $227M (+$10.3M)

0% more funds holding

Funds holding: 84 → 84 (0)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 15

4% less repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 28

Holders
84
Holders Change
–
Holders Change %
0%
% of All Funds
1.92%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
15
Increased
27
Reduced
28
Closed
15
Calls
$189K
Puts
$131K
Net Calls
+$58K
Net Calls Change
+$47K

Top Buyers

1
Russell Investments Group
Russell Investments Group
United Kingdom
+$3.9M
2
LCS
Levin Capital Strategies
New York
+$2.81M
3
SSA
Schonfeld Strategic Advisors
New York
+$858K
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$711K
5
Renaissance Technologies
Renaissance Technologies
New York
+$674K

Top Sellers

1
BlackRock
BlackRock
New York
-$1.21M
2
Goldman Sachs
Goldman Sachs
New York
-$813K
3
Northern Trust
Northern Trust
Illinois
-$602K
4
Millennium Management
Millennium Management
New York
-$540K
5
Morgan Stanley
Morgan Stanley
New York
-$498K
Name Holding Trade Value Shares
Change 		Change in
Stake
Two Sigma Investments
26
Two Sigma Investments
New York
$912K +$66.9K +11,731 +8%
IP
27
Intellectus Partners
California
$809K – – –
WMSA
28
Weiss Multi-Strategy Advisers
New York
$793K -$182K -31,999 -19%
Invesco
29
Invesco
Georgia
$734K +$348K +60,997 +98%
Deutsche Bank
30
Deutsche Bank
Germany
$695K +$73.3K +12,858 +12%
ECM
31
Endurant Capital Management
California
$680K +$650K +114,110 New
Two Sigma Advisers
32
Two Sigma Advisers
New York
$481K +$143K +25,100 +45%
TCIM
33
TIAA CREF Investment Management
New York
$466K -$44.1K -7,739 -9%
Jennison Associates
34
Jennison Associates
New York
$410K +$163K +28,520 +71%
Morgan Stanley
35
Morgan Stanley
New York
$397K -$498K -87,469 -57%
TA
36
Teachers Advisors
New York
$340K -$13.7K -2,412 -4%
PP
37
Paloma Partners
Connecticut
$339K +$227K +39,900 +235%
Charles Schwab
38
Charles Schwab
California
$327K -$97.5K -17,100 -24%
California Public Employees Retirement System
39
California Public Employees Retirement System
California
$324K – – –
Goldman Sachs
40
Goldman Sachs
New York
$315K -$813K -142,637 -73%
Wells Fargo
41
Wells Fargo
California
$292K +$114K +19,972 +69%
AllianceBernstein
42
AllianceBernstein
Tennessee
$272K +$12.5K +2,200 +5%
OAM
43
Oxford Asset Management
United Kingdom
$240K -$413K -72,534 -65%
PPA
44
Parametric Portfolio Associates
Washington
$240K +$12.9K +2,266 +6%
Los Angeles Capital Management
45
Los Angeles Capital Management
California
$240K +$229K +40,210 New
California State Teachers Retirement System (CalSTRS)
46
California State Teachers Retirement System (CalSTRS)
California
$239K -$113K -19,749 -33%
FC
47
Fairpointe Capital
Illinois
$238K +$228K +40,000 New
Susquehanna International Group
48
Susquehanna International Group
Pennsylvania
$214K +$205K +35,958 New
Nisa Investment Advisors
49
Nisa Investment Advisors
Missouri
$188K – – –
PP
50
PDT Partners
New York
$165K -$44K -7,717 -22%
1
2
3 4

LAB Hedge Fund Activity: Q2 2018 in Review

84 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q2 2018, worth a combined $227M — up 4.7% from $217M a quarter earlier.

Fund positioning in LAB was balanced in Q2 2018: 15 funds opened new positions, 15 closed out, 27 added to existing stakes and 28 trimmed.

The largest buyer was Russell Investments Group, adding an estimated $3.9M. The largest seller was BlackRock, cutting an estimated $1.21M.

  • 84 institutional investors held Standard BioTools (LAB) as of Q2 2018, unchanged from Q1 2018.
  • Funds reported $227M of Standard BioTools stock for Q2 2018, up 4.7% quarter-over-quarter.
  • 15 funds opened new Standard BioTools positions in Q2 2018 and 15 closed out, a net change of 0 holders.
  • The largest Standard BioTools buyer in Q2 2018 was Russell Investments Group, an estimated $3.9M added.
  • The largest Standard BioTools seller in Q2 2018 was BlackRock, an estimated $1.21M sold.

Based on aggregated 13F filings for Q2 2018.